Nutriband Inc. NTRBW
Set alert
As of Sep 30, 3:59 PM ET
- YTD
- -65.84%
- 1 year
- -62.84%
- Open
- 2.61
- Prev close
- 1.73
- Mkt cap
- 6.69M
- Vol
- 46.06K
- Avg vol
- 6.25K
- EPS
- -0.505
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.3414
- High
- 1.50
- Forward P/E
- 0.00
- Beta
- 0.42
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.51
- 200-d avg
- 1.14
- 1y target
- 0.00
News
2 weeks ago globenewswire.com
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
ORLANDO, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB), announced today that it has seen 272,671 NTRBW warrants exercised at a strike price of $6.43 for proceeds to the company…
3 weeks ago globenewswire.com
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
Nutriband files new non-provisional patent application to strengthen intellectual property protection of its AVERSA™ transdermal abuse deterrent technology being developed for patches containing…
1 month ago globenewswire.com
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Nutriband CEO Gareth Sheridan Congratulates Shareholders on Five-Year Nasdaq Listing Anniversary CEO letter reflects on five years of milestones since the Company's October 1, 2021 uplisting, as…
1 month ago globenewswire.com
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
ORLANDO, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that its CEO, Gareth Sheridan, has been featured in a new documentary by independent…
1 month ago defenseworld.net
Nutriband Inc. (NASDAQ:NTRBW) Short Interest Update
Nutriband Inc. (NASDAQ: NTRBW - Get Free Report) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totaling 4,262 shares, a growth of…
1 month ago globenewswire.com
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
ORLANDO, Fla., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) confirmed today that its outstanding warrants (NASDAQ:NTRBW) will expire on September 30, 2026 at 5PM ET…
1 month ago globenewswire.com
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
ORLANDO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO, Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on…
1 month ago globenewswire.com
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse deterrent fentanyl…
2 months ago globenewswire.com
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life…
5 months ago globenewswire.com
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
Nutriband's Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference Company to Meet with Buyers from Walmart Inc,…
6 months ago globenewswire.com
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
ORLANDO, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan has featured on the latest episode of the…
7 months ago globenewswire.com
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance. Nutriband…
8 months ago globenewswire.com
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
ORLANDO, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica…
9 months ago globenewswire.com
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
ORLANDO, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) has provided an update to shareholders on the key milestones and discussions from this years Annual…
10 months ago globenewswire.com
Nutriband CEO Publishes Letter to Shareholders
ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on…
10 months ago globenewswire.com
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe…
10 months ago defenseworld.net
Nutriband (NASDAQ:NTRBW) Trading 0.7% Higher – Should You Buy?
Nutriband Inc. (NASDAQ: NTRBW - Get Free Report) shares shot up 0.7% during mid-day trading on Friday. The stock traded as high as $1.52 and last traded at $1.52. 104 shares were traded during…
10 months ago globenewswire.com
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid…
11 months ago defenseworld.net
Nutriband (NASDAQ:NTRBW) Shares Down 5% – What’s Next?
Nutriband Inc. (NASDAQ: NTRBW - Get Free Report)'s stock price traded down 5% during mid-day trading on Thursday. The company traded as low as $0.80 and last traded at $1.33. 210 shares changed hands…
11 months ago newsfilecorp.com
Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference
Orlando, Florida--(Newsfile Corp. - November 24, 2025) - Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that its Chairman and Co-Founder, Serguei Melnik will present at NobleCon21 -…